1 Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, L693GF, UK; MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, L69 3GE, UK; Tandem Nano Ltd., Foundation Building, 765 Brownlow Hill, Liverpool, L69 7ZX, UK.
Linked Articles:
This article is part of a themed section on Nanomedicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2014.171.issue-17